KK

Krishanu Kumar Bhagabati

Active Director Director DIN 11218637
DIN 11218637 First appointment Jul 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Krishanu Kumar Bhagabati

Data last updated:

Krishanu Kumar Bhagabati is a Director at Bionesk Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11218637
Primary Designation Director
Industry Pharma
First Appointment 28 Jul 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Bionesk Lifesciences Private Limited U46497AS2025PTC028613
Director28 Jul 20252025Active

Board colleagues of Krishanu Kumar Bhagabati

Directorship timeline

Open interactive timeline →
Bionesk Lifesciences Private Limited
Premium access

Shareholding and investment profile for Krishanu Kumar Bhagabati

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Krishanu Kumar Bhagabati

Krishanu Kumar Bhagabati currently holds 1 directorship: Bionesk Lifesciences Private Limited (Director, since 28 Jul 2025).

Krishanu Kumar Bhagabati was first appointed on 28 Jul 2025 as Director at Bionesk Lifesciences Private Limited.

The current boards of Krishanu Kumar Bhagabati's companies include Biswajit Das (Bionesk Lifesciences Private Limited), Nitul Kalita (Bionesk Lifesciences Private Limited), Sandip Sarmah (Bionesk Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available